Table 4.
Pre-treatment pathogens isolated from patients with complicated skin and soft tissue infections (Fabian et al 2005)
| Total pathogens | 1444 | (100%) |
|---|---|---|
| Gram-positive aerobes | 827 | (57%) |
| Staphylococcus aureus (MS) | 295 | (20%) |
| Staphylococcus aureus (MR) | 118 | (8%) |
| Streptococcus pyogenes | 89 | (6%) |
| Streptococcus agalactiae | 59 | (4%) |
| Enterococcus faecalis | 52 | (4%) |
| Gram-negative aerobes | 378 | (26%) |
| Escherichia coli | 64 | (4%) |
| Pseudomonas aeruginosa | 53 | (4%) |
| Proteus spp. | 52 | (4%) |
| Klebsiella spp. | 41 | (3%) |
| Anaerobes | 239 | (17%) |
| Bacteroides fragilis | 74 | (5%) |
| Peptostreptococcus spp. | 63 | (4%) |
| Prevotella spp. | 46 | (3%) |
| Monomicrobial infections | 895 | (62%) |
| Polymicrobial infections | 549 | (38%) |
Abbreviations: MS, methicillin-susceptible; MR, methicillin-resistant.